# Stellate Ganglion Blockade in Post-Menopausal Women

> **NCT02907983** · PHASE2 · WITHDRAWN · sponsor: **Northwestern University**

## Conditions studied

- Hot Flashes
- Hot Flushes
- Vasomotor Symptoms

## Interventions

- **DRUG:** Stellate Ganglion Block Injection with Bupivicaine
- **DRUG:** Saline injection

## Key facts

- **NCT ID:** NCT02907983
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-07-10
- **Primary completion:** 2023-08-24
- **Final completion:** 2023-08-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Audit panel terminated IRB approval and closed the study study.
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907983, "Stellate Ganglion Blockade in Post-Menopausal Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02907983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*